Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See More
Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreDear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Flow cytometric analysis of CD68 expression on human peripheral blood monocytes. Human peripheral blood mononuclear cells were fixed and permeabilized with BD Cytofix/Cytoperm™ Fixation/Permeabilization Solution (Cat. No. 554722). After washing with BD Perm/Wash™ Buffer (Cat. No. 554723), the cells were stained with either FITC Mouse Anti-Human CD68 antibody (Cat. No. 562117; solid line histogram) or with a FITC Mouse IgG2b, κ Isotype Control (Cat. No. 555057; dashed line histogram). The fluorescence histograms were derived from events with the forward and side light-scatter characteristics of intact monocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CD68 expression on human peripheral blood monocytes. Human peripheral blood mononuclear cells were fixed and permeabilized with BD Cytofix/Cytoperm™ Fixation/Permeabilization Solution (Cat. No. 554722). After washing with BD Perm/Wash™ Buffer (Cat. No. 554723), the cells were stained with either FITC Mouse Anti-Human CD68 antibody (Cat. No. 562117; solid line histogram) or with a FITC Mouse IgG2b, κ Isotype Control (Cat. No. 555057; dashed line histogram). The fluorescence histograms were derived from events with the forward and side light-scatter characteristics of intact monocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CD68 expression on human peripheral blood monocytes. Human peripheral blood mononuclear cells were fixed and permeabilized with BD Cytofix/Cytoperm™ Fixation/Permeabilization Solution (Cat. No. 554722). After washing with BD Perm/Wash™ Buffer (Cat. No. 554723), the cells were stained with either FITC Mouse Anti-Human CD68 antibody (Cat. No. 562117; solid line histogram) or with a FITC Mouse IgG2b, κ Isotype Control (Cat. No. 555057; dashed line histogram). The fluorescence histograms were derived from events with the forward and side light-scatter characteristics of intact monocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
The Y1/82A monoclonal antibody specifically binds to CD68 which is also known as, Scavenger receptor class D member 1 (SCARD1), Macrosialin, or GP110. CD68 is a cell surface 110 kDa-type I-transmembrane glycoprotein that is primarily expressed in cytoplasmic granules of monocytes, macrophages, dendritic cells, granulocytes, myeloid progenitor cells and, reportedly, a subset of CD34-positive hemopoietic bone marrow progenitor cells. CD68 belongs to the sialomucin family and serves as a scavenger receptor that can bind and internalize oxidized low density lipoproteins (LDL). This antibody is useful in studies of myeloid cell development and function.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.
Refer to manufacturer's instructions for use and related User Manuals and Technical Data Sheets before using this product as described.
Comparisons, where applicable, are made against older BD technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.